{
  "meta": {
    "title": "Respiratory_System",
    "url": "https://brainandscalpel.vercel.app/respiratory-system-141d185c.html",
    "scrapedAt": "2025-11-29T18:34:05.735Z"
  },
  "questions": [
    {
      "id": 10847,
      "choices": [
        {
          "id": 43354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac failure</span></span></span></p>"
        },
        {
          "id": 43355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchial asthma</span></span></span></p>"
        },
        {
          "id": 43356,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic failure</span></span></span></p>"
        },
        {
          "id": 43357,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arthritis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of 5-lipoxygenase is useful in. </span></span></span></p>",
      "unique_key": "Q9438754",
      "question_audio": null,
      "question_video": null,
      "map_id": 10894,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Bronchial asthma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5-lipoxygenase</strong> is a crucial enzyme involved in the <strong>production of leukotrienes</strong>, <strong>potent inflammatory mediators</strong> significantly involved in the <strong>pathophysiology of bronchial asthma</strong>. I<strong>nhibiting</strong> this <strong>enzyme reduces leukotriene production</strong>, effectively <strong>decreasing</strong> <strong>inflammation and improving symptoms in asthma </strong>patients. Drugs like <strong>zileuton target 5-lipoxygenase, </strong>highlighting its specific use in managing asthma by<strong> controlling leukotriene-driven inflammatory processes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cardiac failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> There is <strong>no</strong> established <strong>use of 5-lipoxygenase inhibitors</strong> in the treatment of <strong>cardiac failure, as leukotrienes</strong> <strong>do not</strong> play a significant role in this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hepatic failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similarly,<strong> inhibiting 5-lipoxygenase </strong>is<strong> not a</strong> therapeutic approach in<strong> hepatic failure,</strong> where <strong>leukotrienes</strong> are <strong>not</strong> a primary concern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Arthritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although <strong>leukotrienes contribute to inflammation, 5-lipoxygenase inhibitors</strong> are <strong>not</strong> commonly used in <strong>arthritis</strong>. Other <strong>anti-inflammatory drugs</strong> are preferred for their<strong> broader efficacy in treating joint inflammation and pain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5-lipoxygenase inhibition</strong> is specifically<strong> beneficial in asthma </strong>management <strong>due to its role</strong> in <strong>reducing leukotriene production,</strong> a key <strong>component of the inflammatory response in asthma.</strong></span></span></p>",
      "correct_choice_id": 43355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10862,
      "choices": [
        {
          "id": 43414,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salbutamol</span></span></span></p>"
        },
        {
          "id": 43415,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></span></p>"
        },
        {
          "id": 43416,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theophylline</span></span></span></p>"
        },
        {
          "id": 43417,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following drugs are used in treatment or prophylaxis of bronchial asthma except.</span></span></span></p>",
      "unique_key": "Q7477670",
      "question_audio": null,
      "question_video": null,
      "map_id": 10909,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Morphine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Morphine</strong> is generally <strong>avoided</strong> in <strong>asthma treatment </strong>because it can <strong>release histamine,</strong> which may <strong>provoke bronchospasm</strong> and <strong>worsen asthma symptoms</strong>. This characteristic makes it<strong> contraindicated for patients with asthma,</strong> especially<strong> during acute</strong> <strong>exacerbations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Salbutamol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Widely used as a <strong>rescue medication in asthma </strong>for its<strong> rapid bronchodilatory effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Theophylline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>methylxanthine drug </strong>that provides<strong> bronchodilation </strong>by <strong>inhibiting phosphodiesterase</strong> and has <strong>some anti-inflammatory properties.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Steroids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Essential for<strong> controlling chronic inflammation in asthma;</strong> used <strong>both in acute management </strong>and for <strong>long-term</strong> <strong>control.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine can worsen asthma symptoms due to histamine release, making it unsuitable for asthma patients</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs used in Asthma</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture6_BScoSQZ.jpg\" style=\"height:532px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture7_OMtFvT4.jpg\" style=\"height:349px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 43415,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10866,
      "choices": [
        {
          "id": 43430,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elderly patient</span></span></span></p>"
        },
        {
          "id": 43431,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Concomitant use of fluoroquinolones</span></span></span></p>"
        },
        {
          "id": 43432,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic smoker</span></span></span></p>"
        },
        {
          "id": 43433,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic insufficiency</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following conditions warrant reduction in dose of theophylline in asthma except. </span></span></span></p>",
      "unique_key": "Q9419625",
      "question_audio": null,
      "question_video": null,
      "map_id": 10913,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Chronic smoker</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Theophylline</strong> is a <strong>bronchodilator</strong> that also has <strong>anti-inflammatory effects </strong>and can <strong>improve mucociliary clearance</strong>. It acts by<strong> inhibiting phosphodiesterase enzymes</strong>, leading to an <strong>increase in intracellular levels of cAMP, </strong>which results in <strong>bronchodilation.</strong> <strong>Chronic</strong> <strong>smokers </strong>may require<strong> higher doses of theophylline</strong> because <strong>smoking induces certain liver enzymes (specifically cytochrome P450</strong> enzymes), <strong>which increase the metabolism of theophylline</strong>. This induction necessitates a <strong>higher dose to achieve therapeutic drug levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Elderly patient:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Theophylline metabolism decreases</strong> with <strong>age</strong> due to<strong> reduced liver and kidney function.</strong> Elderly patients generally require <strong>lower doses to prevent toxicity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Concomitant use of fluoroquinolones:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fluoroquinolones<strong> inhibit the metabolism of theophylline, </strong>which can <strong>lead to higher</strong> <strong>plasma concentrations </strong>and <strong>potential toxicity.</strong> Therefore, <strong>dose reductions</strong> are necessary when <strong>theophylline</strong> is used concurrently with <strong>fluoroquinolones.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hepatic insufficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Liver disease</strong> significantly <strong>impairs theophylline clearance</strong>, necessitating a <strong>dose reduction to avoid</strong> <strong>toxic levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Educational Objective:</u></span></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic smokers </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">may require</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> increased doses of theophylline </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">due to enhanced </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">metabolism by induced liver enzymes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dose Adjustments of Theophylline</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture8.jpg\" style=\"height:337px; width:1000px\" /></p>",
      "correct_choice_id": 43432,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10852,
      "choices": [
        {
          "id": 43374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac arrhythmias</span></span></span></p>"
        },
        {
          "id": 43375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diuresis</span></span></span></p>"
        },
        {
          "id": 43376,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seizures</span></span></span></p>"
        },
        {
          "id": 43377,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GI discomfort</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All adverse effects of theophylline are mediated by A1 receptor except? </span></span></span></p>",
      "unique_key": "Q1364977",
      "question_audio": null,
      "question_video": null,
      "map_id": 10899,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. GI discomfort</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theophylline&#39;s adverse effects such as <strong>cardiac arrhythmias, diuresis, and seizures </strong>are generally mediated by its <strong>action</strong> as an <strong>adenosine A1 receptor antagonist.</strong> This mechanism involves <strong>blocking adenosine&rsquo;s normal protective roles,</strong> which can<strong> lead to</strong> these <strong>effects</strong>. However, <strong>GI discomfort</strong>, including <strong>nausea and vomiting,</strong> is primarily caused by <strong>theophylline&rsquo;s inhibition</strong> of <strong>phosphodiesterase-4 (PDE-4), </strong>not by adenosine A1 receptor antagonism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cardiac arrhythmias:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These are associated with <strong>adenosine A1 receptor antagonism</strong>, which can <strong>increase </strong>the likelihood of <strong>arrhythmias </strong>due to<strong> increased cardiac excitability.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Diuresis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Theophylline increases urine production</strong> partly through its<strong> antagonistic effects on adenosine A1 receptors, </strong>which <strong>normally promote sodium and water reabsorption.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Seizures:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also mediated by <strong>adenosine A1 receptor antagonism;</strong> <strong>adenosine</strong> typically has a <strong>neuroprotective role,</strong> and <strong>blocking its receptors</strong> increases seizure risk.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Side effects of theophylline and proposed mechanisms</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture2_UZNUPoT.jpg\" style=\"height:218px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 43377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10860,
      "choices": [
        {
          "id": 43406,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of leukotriene D4 receptor</span></span></span></p>"
        },
        {
          "id": 43407,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of 5-lipoxygenase</span></span></span></p>"
        },
        {
          "id": 43408,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antagonism of muscarinic receptors</span></span></span></p>"
        },
        {
          "id": 43409,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of phosphodiesterase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female patient with a history of asthma presents to the clinic with worsening shortness of breath, cough, and wheezing. Her asthma is typically well-controlled with inhaled glucocorticoids and short-acting beta-2 agonists as needed, but she reports increased symptoms over the past several days. The patient is started on montelukast as an adjunct therapy. What is the mechanism of action of montelukast?</span></span></span></p>",
      "unique_key": "Q2330960",
      "question_audio": null,
      "question_video": null,
      "map_id": 10907,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Inhibition of leukotriene D4 receptor.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Montelukast</strong> works by <strong>selectively inhibiting the leukotriene D4 receptor,</strong> part of the pathway that <strong>leads to inflammation,</strong> <strong>bronchoconstriction,</strong> and <strong>mucus production in asthma.</strong> By blocking the <strong>action of leukotrienes</strong>, <strong>montelukast reduces airway edema,</strong> <strong>smooth muscle contraction, and inflammation, </strong>making it an <strong>effective controller medication</strong> for <strong>chronic asthma management </strong>and for<strong> preventing exercise-induced bronchospasm.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Inhibition of 5-lipoxygenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the <strong>action of drugs like zileuton</strong>, not montelukast, and involves <strong>stopping leukotriene</strong> <strong>synthesis</strong> at an earlier stage in the pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Antagonism of muscarinic receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically associated with <strong>anticholinergic drugs like ipratropium</strong>, which are used to <strong>relax airway smooth muscles</strong> via a<strong> different mechanism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inhibition of phosphodiesterase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Associated with drugs like <strong>theophylline</strong>, which<strong> increase cAMP levels </strong>in<strong> smooth muscle</strong> <strong>cells, leading to bronchodilation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Montelukast blocks leukotriene D4 receptors, </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">crucial for managing </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">chronic asthma and preventing exercise-induced bronchospasm.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This mechanism highlights its role beyond <strong>immediate symptom relief, focusing on long-term asthma control.</strong></span></span></span></span></span></p>",
      "correct_choice_id": 43406,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10849,
      "choices": [
        {
          "id": 43362,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antagonize leukotriene D4 receptor.</span></span></span></p>"
        },
        {
          "id": 43363,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits 5-lipoxygenase.</span></span></span></p>"
        },
        {
          "id": 43364,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibit phosphodiesterase&rsquo;s.</span></span></span></p>"
        },
        {
          "id": 43365,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulate beta 2 receptors.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man with a long history of asthma is referred to pulmonologist. The physician decides to prescribe zileuton. The mechanism of action of this drug is to?</span></span></span></p>",
      "unique_key": "Q8144755",
      "question_audio": null,
      "question_video": null,
      "map_id": 10896,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Inhibits 5- lipoxygenase.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zileuton</strong> works by <strong>inhibiting 5-lipoxygenase</strong>, an enzyme involved in the <strong>synthesis of leukotrienes</strong>, which are key mediators in the <strong>inflammatory process associated with asthma. </strong>By <strong>reducing leukotriene production</strong>, zileuton <strong>decreases inflammation and</strong> <strong>respiratory symptoms in asthma patients</strong>, making it an <strong>effective treatment </strong>for managing <strong>chronic asthma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Antagonize leukotriene D4 receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the mechanism of<strong> leukotriene receptor antagonists like montelukast and</strong> <strong>zafirlukast, </strong>not zileuton.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Inhibit phosphodiesterase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the <strong>action of drugs</strong> like <strong>theophylline,</strong> which are used as <strong>bronchodilators </strong>and <strong>anti-inflammatory agents </strong>but are unrelated to the mechanism of zileuton.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Stimulate beta 2 receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This describes the<strong> action of beta-2 agonists </strong>such as<strong> salbutamol and terbutaline,</strong> which are used as <strong>rescue inhalers for acute asthma exacerbations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zileuton&#39;s ability</strong> to <strong>inhibit the 5-lipoxygenase enzyme</strong> and thus<strong> decrease leukotriene production</strong> is vital for its <strong>effectiveness in</strong> <strong>asthma management,</strong> <strong>targeting</strong> a specific part of the <strong>inflammatory pathway.</strong></span></span></span></span></span></p>",
      "correct_choice_id": 43363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10853,
      "choices": [
        {
          "id": 43378,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beclomethasone</span></span></span></p>"
        },
        {
          "id": 43379,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone</span></span></span></p>"
        },
        {
          "id": 43380,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Budesonide</span></span></span></p>"
        },
        {
          "id": 43381,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluticasone acetonide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an inhalational corticosteroid?</span></span></span></p>",
      "unique_key": "Q1540177",
      "question_audio": null,
      "question_video": null,
      "map_id": 10900,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Betamethasone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Betamethasone </strong>is primarily used as a <strong>systemic corticosteroid</strong> and is typically <strong>administered orally or via injection.</strong> It is known for its <strong>potent anti-inflammatory effects</strong> but is<strong> not</strong> formulated as an <strong>inhalational corticosteroid </strong>for treating <strong>respiratory conditions like</strong> <strong>asthma</strong>. <strong>Inhalational corticosteroids </strong>are designed to deliver <strong>direct anti-inflammatory effects</strong> to the <strong>airways, minimizing systemic</strong> <strong>absorption </strong>and associated<strong> side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Beclomethasone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an <strong>inhalational corticosteroid </strong>commonly used in the management of <strong>asthma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Budesonide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also an <strong>inhalational corticosteroid,</strong> frequently used to <strong>control and prevent</strong> symptoms in <strong>asthma and COPD.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fluticasone acetonide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Utilized as an <strong>inhalational corticosteroid,</strong> effective in <strong>reducing airway inflammation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhalational Corticosteroids</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture3.jpg\" style=\"height:561px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 43379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10848,
      "choices": [
        {
          "id": 43358,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salbutamol</span></span></span></p>"
        },
        {
          "id": 43359,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipratropium</span></span></span></p>"
        },
        {
          "id": 43360,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Montelukast</span></span></span></p>"
        },
        {
          "id": 43361,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrocortisone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug not used in acute asthma is. </span></span></span></p>",
      "unique_key": "Q9513901",
      "question_audio": null,
      "question_video": null,
      "map_id": 10895,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Montelukast</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Montelukast</strong>, a l<strong>eukotriene receptor antagonist</strong>, is primarily utilized for<strong> long-term control of asthma</strong> and to <strong>prevent exercise-induced bronchoconstriction. </strong>It is <strong>not</strong> suited for<strong> acute asthma management</strong> because it <strong>does not</strong> provide <strong>immediate</strong> <strong>bronchodilation, </strong>which is critical during an<strong> asthma attack. </strong>Its role in asthma management is <strong>preventative rather than responsive,</strong> making it <strong>ineffective in emergency situations </strong>where<strong> rapid symptom relief is necessary.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Salbutamol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>short-acting beta-2 agonist </strong>frequently used for<strong> immediate relief in acute asthma</strong> due to its <strong>rapid</strong> o<strong>nset of action in bronchodilation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ipratropium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An <strong>anticholinergic used </strong>as an adjunct with<strong> beta-2 agonists </strong>for <strong>acute asthma exacerbations</strong>, providing <strong>additional bronchodilation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hydrocortisone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>systemic corticosteroid </strong>often used in<strong> acute asthma to reduce inflammation and improve symptoms,</strong> particularly in<strong> severe cases </strong>or those <strong>not responding adequately to bronchodilator</strong>s.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Montelukast</strong> is<strong> not </strong>used for <strong>acute asthma attacks</strong> due to its <strong>lack of rapid bronchodilatory effects</strong>, underscoring the importance of <strong>selecting</strong> appropriate medications for<strong> immediate versus long-term asthma management.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only <strong>bronchodilator drugs</strong> are <strong>useful </strong>for the treatment of<strong> acute attack of asthma.</strong> Main drugs are: </span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta 2 agonists e.g., salbutamol, terbutaline</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticholinergics e.g., ipratropium, tiotropium</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylxanthines e.g., theophylline </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition,<strong> steroids like hydrocortisone </strong>are used for the treatment of<strong> status asthmaticus. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other drugs used for asthma (like <strong>mast cell stabilizers, leukotriene receptor antagonists and lipoxygenase inhibitors</strong>) are<strong> indicated</strong> only for<strong> prophylaxis.</strong></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 43360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10850,
      "choices": [
        {
          "id": 43366,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are used alone for the treatment of acute attacks of asthma.</span></span></span></p>"
        },
        {
          "id": 43367,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They have high systemic activity.</span></span></span></p>"
        },
        {
          "id": 43368,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are superior to &beta;2 agonists in symptom control.</span></span></span></p>"
        },
        {
          "id": 43369,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral candidiasis can occur as a side effect.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Select the correct statement regarding use of inhaled glucocorticoids in bronchial asthma? </span></span></span></p>",
      "unique_key": "Q5522458",
      "question_audio": null,
      "question_video": null,
      "map_id": 10897,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Oral candidiasis can occur as a side effect.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhaled glucocorticoids</strong> are crucial for the <strong>long-term management of asthma </strong>due to their <strong>anti-inflammatory properties</strong>. One of the c<strong>ommon side effects</strong> of inhaled<strong> glucocorticoids is oral candidiasis.</strong> This <strong>fungal infection</strong> can develop due to the <strong>local</strong> <strong>immunosuppressive action of glucocorticoids in the mouth,</strong> <strong>fostering fungal growth</strong>.<strong> Proper inhaler technique</strong>, including <strong>mouth</strong> <strong>rinsing after use</strong>, is recommended to<strong> minimize this risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. They are used alone for the treatment of acute attacks of asthma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>incorrect </strong>as i<strong>nhaled glucocorticoids</strong> <strong>do not</strong> provide the<strong> immediate symptom relief </strong>required during an<strong> acute asthma attack.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. They have high systemic activity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Inhaled glucocorticoids </strong>are designed to <strong>minimize systemic absorption</strong>, thus reducing s<strong>ystemic side effects</strong> compared to<strong> oral glucocorticoids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. They are superior to &beta;2 agonists in symptom control:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect</strong> as <strong>&beta;2 agonists</strong> are the drugs of choice for <strong>immediate relief of symptoms</strong> due to their <strong>rapid bronchodilatory effects</strong>, whereas<strong> inhaled glucocorticoids</strong> are used for <strong>long-term</strong> <strong>control and prevention of symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The potential for <strong>developing oral candidiasis</strong> is a significant consideration when using<strong> inhaled glucocorticoids for asthma</strong> management, emphasizing the <strong>importance of proper inhaler use and oral hygiene practices</strong></span></span></span></span></span></p>",
      "correct_choice_id": 43369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10861,
      "choices": [
        {
          "id": 43410,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theophylline</span></span></span></p>"
        },
        {
          "id": 43411,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Omalizumab</span></span></span></p>"
        },
        {
          "id": 43412,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zafirlukast</span></span></span></p>"
        },
        {
          "id": 43413,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salbutamol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which anti-asthmatic drug X act through the mechanism as shown in figure:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture5_Kd14fvk.jpg\" style=\"height:578px; width:700px\" /></span></span></span></p>",
      "unique_key": "Q5462521",
      "question_audio": null,
      "question_video": null,
      "map_id": 10908,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Omalizumab</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Omalizumab</strong> is a <strong>monoclonal antibody</strong> used for the treatment of<strong> moderate to severe asthma</strong> that <strong>isn&#39;t well-controlled</strong> with standard therapies. It works by <strong>binding to the Fc portion of IgE antibodies</strong>, <strong>preventing</strong> them from <strong>binding to receptors on mast cells</strong> <strong>and basophils</strong>. This mechanism <strong>blocks the allergic response, reducing inflammation and improving asthma symptoms</strong>. <strong>Omalizumab</strong> specifically targets th<strong>e immunologic aspect of asthma</strong> by<strong> modulating the allergic cascade</strong> that leads to <strong>asthma exacerbation</strong>s. By <strong>blocking the binding of IgE to its receptors</strong>, omalizumab can<strong> reduce the allergic response </strong>in the airways, which can help to <strong>reduce</strong> <strong>inflammation and improve asthma symptoms</strong>. Specifically, omalizumab can:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reduce</strong> the release <strong>of inflammatory mediators from mast cells and basophils.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reduce</strong> the recruitment of<strong> inflammatory cells to the airways.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reduce</strong> the <strong>hyperresponsiveness of the airways</strong> to <strong>allergens and other triggers.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Theophylline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Works by <strong>inhibiting phosphodiesterase and antagonizing adenosine receptors,</strong> leading to <strong>bronchodilation</strong> and some <strong>anti-inflammatory effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Zafirlukast:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A l<strong>eukotriene receptor antagonist</strong> that<strong> blocks </strong>the <strong>action of leukotrienes</strong> on their receptors, helping to <strong>control</strong> <strong>asthma symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Salbutamol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>short-acting beta-2 agonist</strong> that <strong>stimulates receptors</strong> to cause <strong>bronchodilation,</strong> providing <strong>quick relief </strong>from <strong>asthma symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Omalizumab targets IgE to prevent allergic reactions that can exacerbate asthma, representing a tailored approach to treating asthma influenced by allergies.</span></span></strong></span></span></span></p>",
      "correct_choice_id": 43411,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10833,
      "choices": [
        {
          "id": 43298,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albuterol</span></span></span></p>"
        },
        {
          "id": 43299,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terbutaline</span></span></span></p>"
        },
        {
          "id": 43300,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metaproterenol</span></span></span></p>"
        },
        {
          "id": 43301,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pirbuterol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following bronchodilator is available for subcutaneous administration?</span></span></span></p>",
      "unique_key": "Q5729089",
      "question_audio": null,
      "question_video": null,
      "map_id": 10880,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Terbutaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Terbutaline</strong> is a <strong>beta-2 agonist bronchodilator</strong> that can be administered <strong>subcutaneously,</strong> intravenously, or by inhalation. It is used to treat<strong> acute severe asthma, bronchospasm,</strong> and to <strong>prevent premature labor</strong>. Subcutaneous administration of <strong>terbutaline </strong>is utilized in <strong>emergency situations</strong> where r<strong>apid relief of bronchospasm</strong> is necessary, such as in the treatment of <strong>status asthmaticus or acute</strong> <strong>severe asthma attacks.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Albuterol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This bronchodilator is<strong> administered by inhalation or oral routes</strong> and is not given subcutaneously.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metaproterenol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to<strong> albuterol, metaproterenol is also administered by inhalation or oral routes </strong>and lacks a subcutaneous administration option.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pirbuterol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Administered by<strong> inhalation, </strong>pirbuterol is not suitable for subcutaneous use.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Terbutaline</strong> can be <strong>administered subcutaneously,</strong> making it effective for<strong> rapid </strong>management of<strong> severe bronchospasm</strong> in<strong> emergency</strong> <strong>medical situations.</strong></span></span></span></p>",
      "correct_choice_id": 43299,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10835,
      "choices": [
        {
          "id": 43306,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leukotriene antagonists</span></span></span></p>"
        },
        {
          "id": 43307,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipo-oxygenase inhibitors</span></span></span></p>"
        },
        {
          "id": 43308,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta 2 agonists</span></span></span></p>"
        },
        {
          "id": 43309,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticholinergics</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old patient presents to the emergency department with acute onset of wheezing, coughing, and shortness of breath. The patient has a known history of bronchial asthma and reports that the symptoms began after exposure to pollen. Physical examination reveals an increased respiratory rate, use of accessory muscles for breathing, and audible wheezes on auscultation. The patient&#39;s peak expiratory flow rate is significantly reduced compared to the personal best. The attending physician decides to administer medication to relieve the patient&#39;s acute symptoms. Given this clinical scenario, the drug of choice for the acute exacerbation of bronchial asthma is:</span></span></span></p>",
      "unique_key": "Q3358635",
      "question_audio": null,
      "question_video": null,
      "map_id": 10882,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Beta 2 agonists </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta 2 agonists</strong> are the<strong> first-line treatment for acute exacerbations of bronchial asthma. </strong>They work by <strong>rapidly relaxing bronchial</strong> <strong>smooth muscle</strong>, leading to <strong>bronchodilation and relief of symptoms</strong> such as <strong>wheezing, coughing, and shortness of breath.</strong> Fast acting<strong> beta-2 agonists</strong> such as <strong>albuterol (salbutamol), terbutaline and formoterol </strong>provide<strong> quick relief</strong> and are essential in the management of<strong> acute asthma symptoms</strong>. According to <strong>latest GINA guidelines</strong>, combination of<strong> beta 2 agonist formoterol with</strong> <strong>inhalational corticosteroids</strong> i<strong>s treatment of choice </strong>for <strong>acute attack </strong>as well for <strong>prophylaxis of bronchial asthma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leukotriene antagonists:</strong> These are used primarily as l<strong>ong-term control medications</strong> to manage <strong>chronic asthma </strong>and to <strong>prevent symptoms.</strong> They are <strong>not effective</strong> in treating <strong>acute asthma attacks </strong>because they <strong>do not</strong> provide <strong>immediate relief </strong>of <strong>symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B.</strong> <strong>Lipo-oxygenase inhibitors:</strong> Currently, there are <strong>no lipo-oxygenase inhibitors</strong> used in the <strong>clinical management of asthma.</strong> The concept is more related to the <strong>pathway of leukotriene synthesis</strong> but is<strong> not directly</strong> applicable to the<strong> acute management of</strong> <strong>asthma attacks.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinergics:</strong> These medications, such as<strong> ipratropium bromide,</strong> are used in the management of<strong> chronic obstructive</strong> <strong>pulmonary disease (COPD)</strong> and can be added to <strong>beta-2 agonists</strong> for a<strong>cute asthma exacerbations </strong>if <strong>not </strong>adequately controlled by <strong>SABAs alone</strong>. However, they are <strong>not the first choice</strong> for immediate relief of an<strong> acute asthma attack.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary educational objective is to understand the <strong>pharmacological management of acute exacerbations of bronchial asthma.</strong> The key takeaway is that <strong>beta-2 agonists </strong>are the<strong> drug of choice</strong> for <strong>immediate relief of acute asthma symptoms</strong> due to their <strong>rapid</strong> <strong>action in bronchodilation</strong>. Other medications like <strong>leukotriene antagonists and anticholinergics</strong> play a role in the<strong> long-term</strong> <strong>management of asthma or as adjunct therapy in acute settings</strong> but are <strong>not the first-line treatment</strong> for an <strong>acute attack.</strong> Understanding the <strong>role of each medication </strong>class in the management of<strong> asthma</strong> is crucial for <strong>effective treatment and patient care.</strong></span></span></p>",
      "correct_choice_id": 43308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10838,
      "choices": [
        {
          "id": 43318,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in dose is required in congestive heart failure.</span></span></span></p>"
        },
        {
          "id": 43319,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acts by increasing the level of cAMP.</span></span></span></p>"
        },
        {
          "id": 43320,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in dose is required in smokers.</span></span></span></p>"
        },
        {
          "id": 43321,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits phosphodiesterase.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following statements about theophylline are correct except.</span></span></span></p>",
      "unique_key": "Q3671505",
      "question_audio": null,
      "question_video": null,
      "map_id": 10885,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Increase in dose is required in congestive heart failure.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Theophylline is a bronchodilator </strong>that also has <strong>anti-inflammatory effects</strong> and can<strong> improve mucociliary clearance</strong>. It acts by <strong>inhibiting</strong> <strong>phosphodiesterase enzymes,</strong> which leads to an <strong>increase in intracellular levels of cAMP, </strong>resulting in <strong>bronchodilation</strong>. <strong>Smokers </strong>m<span style=\"font-size:16px\">ay require<strong> higher doses of theophylline </strong>due to<strong> increased drug metabolism </strong>caused by <strong>smoking-induced induction of liver</strong> <strong>enzymes.</strong> However, an<strong> increase in dose</strong> is <strong>not </strong>required in patients with<strong> congestive heart failure</strong>. Rather, <strong>c</strong></span></span></span></span><span style=\"font-size:14px\"><strong>ongestive heart failure </strong>can <strong>decrease theophylline</strong> clearance due to <strong>reduced hepatic blood flow </strong>and potential alterations in<strong> liver function </strong>and therefore <strong>dose</strong> <strong>reduction</strong> is necessary to <strong>avoid elevated levels and potential side effects.</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation of other options:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Acts by increasing the level of cAMP:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Correct,</strong> as <strong>theophylline inhibits phosphodiesterase, </strong>which <strong>increases cAMP levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increase in dose is required in smokers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Correct</strong>, due to the<strong> induction of liver enzymes</strong> which <strong>increase theophylline</strong> <strong>metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inhibits phosphodiesterase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Correct, </strong>this is the <strong>primary mechanism </strong>of action for <strong>theophylline.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Theophylline&#39;s</strong> dosing must be <strong>carefully managed,</strong> especially in<strong> smokers </strong>and patients with <strong>congestive heart failure,</strong> due to its <strong>narrow therapeutic index</strong> and <strong>variable metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dose Adjustments of Theophylline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture1_rnSDQQJ.jpg\" style=\"height:408px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 43318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10840,
      "choices": [
        {
          "id": 43326,
          "text": "<p style=\"margin-left:0;\"><span style=\"font-size:12pt;\">Magnesium sulfate</span></p>"
        },
        {
          "id": 43327,
          "text": "<p><span style=\"font-size:12pt;\">Anti-Leukotriene</span></p>"
        },
        {
          "id": 43328,
          "text": "<p><span style=\"font-size:12pt;\">Cromolyn sodium</span></p>"
        },
        {
          "id": 43329,
          "text": "<p><span style=\"font-size:12pt;\">Cyclosporine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following drugs has been found to be useful in acute severe asthma?</span></p>",
      "unique_key": "Q5834597",
      "question_audio": null,
      "question_video": null,
      "map_id": 10887,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A. Magnesium sulfate</strong>&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Magnesium sulfate</strong> is used in the management of <strong>acute severe asthma, </strong>particularly in patients who <strong>do not respond adequately </strong>to <strong>initial treatments</strong> with i<strong>nhaled beta-2 agonists and anticholinergics.</strong> Magnesium sulfate can act as a<strong> bronchodilator,</strong> <strong>reducing</strong> <strong>bronchial smooth muscle contraction </strong>through its <strong>calcium channel blocking effect</strong>, leading to <strong>relaxation of the airway smooth muscle</strong> and thus <strong>improvement in airflow. </strong>Its use is based on the <strong>ability to improve pulmonary function</strong> and <strong>decrease hospital admissions</strong> in patients with <strong>severe asthma exacerbations.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong> <strong>Anti-Leukotriene:</strong> Anti-leukotriene agents, such as <strong>montelukast,</strong> are primarily used as<strong> long-term control medications to</strong> <strong>prevent asthma symptoms and exacerbations. </strong>They are<strong> not</strong> typically used for<strong> immediate relief in the setting of acute severe asthma</strong> because they<strong> do not provide rapid bronchodilation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong> <strong>Cromolyn Sodium:</strong> Cromolyn sodium is a <strong>mast cell stabilizer</strong> that is used for the<strong> prophylactic treatment of asthma</strong>. It works by<strong> preventing the release of mediators from mast cells </strong>that<strong> cause bronchoconstriction and inflammation</strong>. However, it is <strong>not</strong> effective in treating <strong>acute asthma attacks</strong> and is <strong>not </strong>recommended for <strong>acute severe asthma </strong>due to its <strong>mechanism of action and lack</strong> of<strong> immediate effect on bronchodilation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong> <strong>Cyclosporine:</strong> Cyclosporine is an <strong>immunosuppressant drug </strong>primarily used in <strong>transplant medicine to prevent organ</strong> <strong>rejection </strong>and in <strong>certain chronic autoimmune diseases.</strong> It is <strong>not </strong>indicated for the treatment of <strong>asthma, </strong>as its <strong>mechanism of action</strong> <strong>does not </strong>directly address the<strong> acute bronchospasm or inflammation </strong>associated with<strong> asthma exacerbations.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The educational objective is to <strong>identify effective treatments for acute severe asthma. Magnesium sulfate</strong> is an important <strong>adjunctive</strong> therapy in cases of <strong>acute severe asthma</strong> that are <strong>not</strong> responsive to<strong> standard treatments, </strong>due to its <strong>bronchodilatory properties.</strong> Understanding the <strong>roles and mechanisms of various asthma medications,</strong> including why some are <strong>not suitable for acute</strong> <strong>exacerbations,</strong> is crucial for <strong>effectively managing asthma and improving patient outcomes.</strong></span></p>",
      "correct_choice_id": 43326,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10842,
      "choices": [
        {
          "id": 43334,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylbutazone</span></span></span></p>"
        },
        {
          "id": 43335,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naproxen</span></span></span></p>"
        },
        {
          "id": 43336,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocorticoids</span></span></span></p>"
        },
        {
          "id": 43337,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following drugs can precipitate acute attack of asthma except. </span></span></span></p>",
      "unique_key": "Q4484546",
      "question_audio": null,
      "question_video": null,
      "map_id": 10889,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Glucocorticoids</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucocorticoids</strong> are<strong> anti-inflammatory medications</strong> widely used in the management of<strong> asthma to reduce inflammation and</strong> <strong>hyperresponsiveness</strong> of the <strong>airways</strong>. They<strong> do not</strong> precipitate <strong>acute asthma attacks;</strong> instead, they are <strong>crucial in both the prevention</strong> <strong>of asthma exacerbations and the treatment of acute and chronic asthma. </strong>Glucocorticoids can be <strong>administered via inhalation </strong>for <strong>long-term control or systemically for acute severe exacerbations.</strong> <strong>Phenylbutazone</strong> (option a), <strong>naproxen</strong> (option b), and <strong>aspirin</strong> (option d) are all <strong>nonsteroidal anti-inflammatory drugs (NSAIDs)</strong>. These <strong>inhibit COX </strong>and thus <strong>decrease the formation of PGs </strong>from <strong>arachidonic acid. </strong>This results in <strong>diversion of metabolism of arachidonic acid </strong>to produce<strong> LTs.</strong> <strong>Large excess of LTs</strong> is therefore produced with the use of<strong> NSAIDs</strong>. These drugs, therefore, can<strong> trigger bronchoconstriction </strong>and <strong>worsen asthma</strong> symptoms in <strong>susceptible patients (because LTs are bronchoconstrictors).&nbsp; </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phenylbutazone:</strong> This is a<strong> non-steroidal anti-inflammatory drug (NSAID)</strong> that can <strong>precipitate asthma attacks</strong> in <strong>sensitive</strong> <strong>individuals,</strong> likely due to its effect on<strong> arachidonic acid metabolism leading to increased leukotriene production</strong>, which can cause <strong>bronchoconstriction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Naproxen:</strong> Similar to <strong>phenylbutazone, naproxen is an NSAID </strong>that can also <strong>precipitate asthma attacks</strong> in some patients, particularly those with <strong>aspirin-exacerbated respiratory disease (AERD)</strong>, also known as <strong>aspirin-induced asthma.</strong> NSAIDs can interfere with <strong>prostaglandin synthesis,</strong> leading to <strong>increased leukotriene </strong>production, a<strong> potent bronchoconstrictor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin:</strong> Aspirin can <strong>precipitate asthma attacks</strong> in individuals with<strong> AERD.</strong> This condition is characterized by<strong> asthma, nasal</strong> <strong>polyps, and a sensitivity to aspirin </strong>and <strong>other NSAIDs</strong>. The mechanism involves the<strong> shunting of arachidonic acid metabolism</strong> towards <strong>leukotriene production,</strong> causing <strong>inflammation and bronchoconstriction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to understand the <strong>relationship between</strong> certain <strong>medications and asthma exacerbations</strong>. While <strong>NSAIDs</strong> (like<strong> phenylbutazone, naproxen, and aspirin</strong>) can <strong>precipitate asthma attacks</strong> in <strong>susceptible individuals </strong>due to <strong>their effects </strong>on <strong>arachidonic acid metabolism,</strong> glucocorticoids are fundamental in the <strong>treatment of asthma </strong>for their <strong>anti-inflammatory properties.</strong> Recognizing medications that can <strong>potentially exacerbate asthma</strong> is important in the <strong>care and management of asthma patients.</strong></span></span></p>",
      "correct_choice_id": 43336,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10864,
      "choices": [
        {
          "id": 43422,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipratropium</span></span></span></p>"
        },
        {
          "id": 43423,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salbutamol</span></span></span></p>"
        },
        {
          "id": 43424,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Montelukast</span></span></span></p>"
        },
        {
          "id": 43425,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrocortisone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following drugs are useful in the treatment of acute attack of bronchial asthma except?</span></span></span></p>",
      "unique_key": "Q2074183",
      "question_audio": null,
      "question_video": null,
      "map_id": 10910,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Montelukast</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Montelukast</strong> is a<strong> leukotriene receptor antagonist </strong>primarily used for <strong>maintenance therapy in asthma </strong>and to <strong>prevent exercise-induced bronchospasm</strong>. It is<strong> not </strong>effective as a <strong>rescue medication in acute asthma attacks</strong> because it <strong>does not</strong> provide the <strong>immediate bronchodilatory action </strong>required in such emergencies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Ipratropium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An <strong>anticholinergic</strong> that can be used in <strong>conjunction with beta-2 agonists</strong> to provide <strong>additional</strong> <strong>bronchodilation </strong>during<strong> acute asthma exacerbations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Salbutamol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>short-acting beta-2 agonist</strong>, it is the<strong> primary rescue medication</strong> used to <strong>relieve symptoms</strong> during an <strong>acute</strong> <strong>asthma attack.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hydrocortisone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>corticosteroid </strong>used to manage<strong> severe asthma attacks </strong>by <strong>reducing inflammation and improving</strong> <strong>respiratory function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Montelukast is not used for immediate relief in acute asthma attacks, emphasizing its role in long-term control rather than emergency management.</span></span></strong></span></span></span></p>",
      "correct_choice_id": 43424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10851,
      "choices": [
        {
          "id": 43370,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids facilitate the action of &beta;- agonists.</span></span></span></p>"
        },
        {
          "id": 43371,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids sensitize adenosine receptors to xanthine&rsquo;s.</span></span></span></p>"
        },
        {
          "id": 43372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct bronchodilator action of corticosteroids.</span></span></span></p>"
        },
        {
          "id": 43373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase mucociliary clearance.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A known asthmatic, presented to the emergency with severe exacerbation not relieved by Salbutamol. The patient was given corticosteroids and aminophylline. What is the rationale of giving corticosteroids? </span></span></span></p>",
      "unique_key": "Q9863133",
      "question_audio": null,
      "question_video": null,
      "map_id": 10898,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Corticosteroids facilitate the action of &beta;- agonists.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Corticosteroids</strong> are <strong>potent anti-inflammatory agents</strong> that <strong>reduce airway inflammation</strong> and <strong>improve asthma symptoms.</strong> They <strong>facilitate the action of &beta;-agonists </strong>by <strong>upregulating beta-2 receptors</strong> and<strong> decreasing inflammatory cell activation</strong> and <strong>microvascular</strong> <strong>permeability</strong>. This combination enhances the <strong>effectiveness of &beta;-agonists </strong>in <strong>opening </strong>the<strong> airways </strong>and <strong>relieving asthma symptoms,</strong> making it a critical strategy in managing <strong>acute asthma exacerbations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Corticosteroids sensitize adenosine receptors to xanthines:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>not</strong> a recognized mechanism of action for corticosteroids.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Direct bronchodilator action of corticosteroids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Corticosteroids<strong> do no</strong>t have a direct bronchodilatory effect; their primary function is to<strong> reduce inflammation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increase mucociliary clearance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While corticosteroids may i<strong>mprove overall airway function,</strong> their primary role is<strong> not to</strong> <strong>increase mucociliary clearance,</strong> especially <strong>not</strong> in the <strong>acute management setting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Corticosteroids</strong> are <strong>crucial </strong>in the management o<strong>f acute asthma exacerbation</strong>s primarily due to their <strong>anti-inflammatory properties</strong> and their <strong>ability to enhance the effectiveness of &beta;-agonists.</strong></span></span><strong> </strong></span></span></span></p>",
      "correct_choice_id": 43370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10867,
      "choices": [
        {
          "id": 43434,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reslizumab</span></span></span></p>"
        },
        {
          "id": 43435,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mepolizumab</span></span></span></p>"
        },
        {
          "id": 43436,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benralizumab</span></span></span></p>"
        },
        {
          "id": 43437,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lebrikizumab</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female patient with a long history of severe eosinophilic asthma presents to the clinic. Despite being treated with high-dose inhaled corticosteroids and long-acting beta-agonists, she continues to have frequent asthma exacerbations requiring systemic corticosteroids. After further evaluation, the physician decides to initiate a monoclonal antibody therapy that targets IL-5R. Which of the following medications targets IL-5R and works by antibody-dependent cell-mediated cytotoxicity (ADCC)?</span></span></span></p>",
      "unique_key": "Q1025749",
      "question_audio": null,
      "question_video": null,
      "map_id": 10914,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Benralizumab.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Benralizumab</strong> specifically targets the<strong> IL-5 receptor (IL-5R) on eosinophils and basophils.</strong> It functions through <strong>ADCC </strong>by <strong>attracting</strong> <strong>natural killer (NK) cells to eosinophils and basophils,</strong> leading to their <strong>destruction. </strong>This mechanism is<strong> particularly effective</strong> in <strong>reducing eosinophil levels, </strong>which are often <strong>elevated in eosinophilic asthma</strong> and contribute to the<strong> severity and frequency of asthma</strong> <strong>exacerbations.</strong> <strong>Benralizumab </strong>thus <strong>helps</strong> in significantly <strong>reducing the frequency of exacerbations</strong> in patients with <strong>severe eosinophilic</strong> <strong>asthma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Reslizumab:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Like <strong>mepolizumab, reslizumab targets IL-5 </strong>but <strong>does not work </strong>through <strong>ADCC </strong>and <strong>does not target IL-5R.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Mepolizumab:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This medication also<strong> targets IL-5, </strong>not IL-5R, and works by<strong> inhibiting IL-5 from binding to its receptor</strong> on <strong>eosinophils,</strong> thereby <strong>reducing eosinophil production</strong> and <strong>survival </strong>without involving <strong>ADCC.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lebrikizumab:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Targets interleukin-13 (IL-13),</strong> <strong>not IL-5 or IL-5R,</strong> and is used in the treatment of <strong>asthma </strong>with a different <strong>mechanism of action</strong> than what is specified in the question.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benralizumab targets the IL-5 receptor on eosinophils and basophils and uses ADCC to reduce eosinophil levels, making it effective for patients with severe eosinophilic asthma.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This medication offers a targeted approach for <strong>managing severe, refractory</strong> <strong>eosinophilic asthma</strong> by focusing on a<strong> key inflammatory pathway.</strong></span></span></span></p>",
      "correct_choice_id": 43436,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10868,
      "choices": [
        {
          "id": 43438,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute exacerbation of COPD</span></span></span></p>"
        },
        {
          "id": 43439,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maintenance treatment of COPD</span></span></span></p>"
        },
        {
          "id": 43440,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maintenance treatment of bronchial asthma</span></span></span></p>"
        },
        {
          "id": 43441,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Status asthmaticus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Umeclidinium + vilanterol is recently approved for which of the following diseases? </span></span></span></p>",
      "unique_key": "Q1250159",
      "question_audio": null,
      "question_video": null,
      "map_id": 10915,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Maintenance treatment of COPD</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Umeclidinium and vilanterol </strong>is a combination medication that is used as a maintenance treatment for <strong>chronic obstructive pulmonary</strong> <strong>disease (COPD)</strong>. <strong>Umeclidinium</strong> is a<strong> long-acting anticholinergic medication </strong>that helps to <strong>relax the airway smooth muscle</strong> and <strong>improve breathing.</strong> <strong>Vilanterol</strong> is a <strong>long-acting beta-agonist medication </strong>that helps to stimulate the <strong>beta-2 adrenergic receptors</strong> in the lungs, leading to<strong> bronchodilation.</strong> This <strong>combination </strong>medication is typically used in patients with <strong>moderate to severe COPD</strong> who are <strong>not well-controlled </strong>with other medications such as<strong> inhaled corticosteroids, short-acting bronchodilators, </strong>or<strong> long-acting</strong> <strong>bronchodilators alone</strong>. It is<strong> not </strong>approved for the <strong>treatment of acute exacerbations of COPD, bronchial asthma, </strong>or for the treatment of <strong>status asthmaticus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Acute exacerbation of COPD:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The combination is<strong> not </strong>designed for <strong>acute relief; </strong>it <strong>does not</strong> provide the<strong> immediate</strong> <strong>bronchodilation</strong> necessary for <strong>treating exacerbations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Maintenance treatment of bronchial asthma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>combination</strong> is specifically formulated for <strong>COPD </strong>and is<strong> not indicated</strong> for <strong>asthma treatment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Status asthmaticus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Status asthmaticus requires <strong>immediate, fast-acting interventions, </strong>which this <strong>combination does not provide.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Umeclidinium + vilanterol is</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> approved</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> specifically </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">for the maintenance </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">treatment of COPD, highlighting the importance of tailored therapies for chronic respiratory conditions.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This combination is crucial for continuous management but not suitable for acute respiratory events.</span></span></span></span></span></p>",
      "correct_choice_id": 43439,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10872,
      "choices": [
        {
          "id": 43454,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PDE-3 inhibition</span></span></span></p>"
        },
        {
          "id": 43455,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PDE-4 inhibition</span></span></span></p>"
        },
        {
          "id": 43456,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine A1 receptor antagonism</span></span></span></p>"
        },
        {
          "id": 43457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 agonism</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which mechanism of action of theophylline is responsible for diuresis? </span></span></span></p>",
      "unique_key": "Q5605727",
      "question_audio": null,
      "question_video": null,
      "map_id": 10919,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Adenosine A1 receptor antagonism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Theophylline&#39;s diuretic effect</strong> is primarily attributed to <strong>its action as an adenosine A1 receptor antagonist.</strong> <strong>Adenosine A1 receptors,</strong> when<strong> activated</strong>, play a role in <strong>reducing renal blood flow </strong>and <strong>glomerular filtration rate,</strong> and <strong>enhancing sodium and water</strong> <strong>reabsorption</strong>. By<strong> blocking these receptors,</strong> theophylline can <strong>increase renal blood flow and promote diuresis</strong>, or the<strong> increased</strong> <strong>production of urine</strong>. This mechanism is distinct from its <strong>well-known effects on bronchodilation</strong>, which are <strong>mediated </strong>through other pathways, including <strong>phosphodiesterase inhibition and adenosine receptor antagonism.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PDE-3 inhibition:</strong> <strong>Phosphodiesterase-3 (PDE-3) inhibitors</strong> <strong>increase cAMP levels</strong>, leading to <strong>cardiac and vascular effects,</strong> but they are <strong>not </strong>the primary mechanism for<strong> theophylline&#39;s diuretic effect.</strong> PDE-3 inhibition is more related to<strong> inotropic and</strong> <strong>chronotropic effects on the heart.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PDE-4 inhibition: Phosphodiesterase-4 (PDE-4) inhibition</strong> by <strong>theophylline </strong>plays a role in<strong> anti-inflammatory effects and</strong> <strong>bronchodilation</strong> but is <strong>not </strong>directly responsible for <strong>its diuretic effect</strong>. <strong>PDE-4 </strong>is<strong> more </strong>associated with the <strong>modulation of inflammatory</strong> <strong>cells</strong> in the airways.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 agonism:</strong> While beta-2 agonists can lead to <strong>smooth muscle relaxation and bronchodilation, </strong>theophylline&#39;s diuretic effect is<strong> not </strong>primarily mediated through<strong> beta-2 agonism.</strong> Beta-2 agonists are <strong>not</strong> known for <strong>producing </strong>significant <strong>diuretic effects.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to understand the <strong>multifaceted mechanisms of action of theophylline</strong>, a medication used <strong>primarily </strong>for <strong>respiratory diseases </strong>like asthma and COPD. Specifically, its ability to<strong> antagonize adenosine A1 receptors</strong> contributes to <strong>its diuretic</strong> <strong>effect, </strong>an important consideration in managing patients with <strong>concurrent respiratory and fluid balance issues.</strong> This highlights the need for a<strong> comprehensive </strong>understanding of <strong>drug actions</strong>, particularly for <strong>medications </strong>with <strong>multiple physiological effects.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Side effects of theophylline and proposed mechanisms</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture9.jpg\" style=\"height:238px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 43456,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10844,
      "choices": [
        {
          "id": 43342,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></span></span></p>"
        },
        {
          "id": 43343,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tolerance</span></span></span></p>"
        },
        {
          "id": 43344,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalaemia</span></span></span></p>"
        },
        {
          "id": 43345,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an adverse effect of salbutamol? </span></span></span></p>",
      "unique_key": "Q8193398",
      "question_audio": null,
      "question_video": null,
      "map_id": 10891,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Hypoglycaemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Salbutamol, a beta-2 agonist,</strong> is known to stimulate<strong> glycogenolysis and gluconeogenesis,</strong> which results in an <strong>increase in blood sugar</strong> <strong>levels.</strong> This action directly contradicts the possibility of hypoglycemia as an adverse effect, instead making<strong> hyperglycemia a more</strong> <strong>likely concern, </strong>particularly at <strong>higher dosages or with frequent administration. </strong>This understanding is essential, as<strong> hypoglycemia is</strong> <strong>not</strong> typically associated with<strong> beta-2 agonist effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tachycardia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Salbutamol </strong>can cause<strong> tachycardia, </strong>particularly at <strong>high doses</strong> due to <strong>loss of selectivity for beta-2 receptors,</strong> impacting <strong>heart rate </strong>and potentially<strong> leading to palpitations</strong> or an<strong> uncomfortable awareness of the heartbeat.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Tolerance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> With regular use of<strong> low doses of beta-2 agonists</strong> like <strong>salbutamol,</strong> there is evidence showing a <strong>reduction in the</strong> <strong>bronchodilator response,</strong> indicating <strong>tolerance.</strong> However, <strong>maximal bronchodilation</strong> is <strong>still</strong> achievable within the <strong>usual dosage range.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypokalemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Salbutamol may lead to <strong>hypokalemia</strong> due to an <strong>intracellular shift of potassium</strong>. This side effect is significant because it can result in <strong>changes to the ECG,</strong> indicating disturbances in<strong> heart rhythm </strong>that could be<strong> serious.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adverse Effects of beta-2 agonists </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tremors: </strong>Most common<strong> adverse effect of beta 2 agonists</strong> is tremors. It occurs due to stimulation of<strong> beta 2 receptors on</strong> <strong>skeletal muscle spindles. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tachycardia: </strong>At<strong> high dose</strong>,<strong> beta 2 agonists</strong> can result in <strong>tachycardia due to loss of selectivity.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>T-wave </strong>changes in ECG:<strong> Beta 2 agonists </strong>can result in <strong>hypokalaemia</strong> due to <strong>intracellular shift of potassium.</strong> This can lead to ECG changes.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tolerance</strong>: A <strong>reduction in the bronchodilator response </strong>to <strong>low-dose </strong>&beta;-agonist treatment can be shown<strong> after several days</strong> of <strong>regular &beta;-agonist use</strong>, but <strong>maximal bronchodilation is still </strong>achieved well <strong>within </strong>the <strong>range of doses usually given. </strong></span></span><strong> </strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 43345,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10869,
      "choices": [
        {
          "id": 43442,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cromolyn</span></span></p>"
        },
        {
          "id": 43443,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zileuton</span></span></p>"
        },
        {
          "id": 43444,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Montelukast</span></span></p>"
        },
        {
          "id": 43445,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theophylline</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications inhibits the action of 5-lipoxygenase and consequently the action of leukotriene B4 and the cysteinyl leukotrienes? </span></span></span></p>",
      "unique_key": "Q8220918",
      "question_audio": null,
      "question_video": null,
      "map_id": 10916,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Zileuton</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zileuton</strong> uniquely targets and <strong>inhibits the action of 5-lipoxygenase,</strong> an enzyme crucial in the <strong>leukotriene synthesis pathway</strong>. By i<strong>nhibiting this enzyme,</strong> Zileuton prevents the <strong>formation of leukotriene B4 </strong>and the <strong>cysteinyl leukotrienes</strong>, which are significant contributors to the<strong> inflammatory process in asthma and other inflammatory conditions.</strong> This specific <strong>inhibition </strong>helps manage the <strong>symptoms and progression of asthma</strong> by directly <strong>reducing the levels</strong> of these <strong>potent inflammatory mediators.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cromolyn:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This drug acts as a <strong>mast cell stabilizer</strong> and<strong> prevents </strong>the release of mediators such as <strong>histamine and</strong> leukotrienes but <strong>does not</strong> <strong>inhibit</strong> <strong>leukotriene synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Montelukast:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>leukotriene receptor antagonist</strong>, Montelukast <strong>blocks </strong>the effects of <strong>leukotrienes</strong> once they are produced but<strong> does not</strong> inhibit the <strong>leukotriene-producing enzyme.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Theophylline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Theophylline has<strong> bronchodilatory and anti-inflammatory</strong> effects primarily through <strong>phosphodiesterase</strong> <strong>inhibition </strong>and<strong> adenosine receptor antagonism</strong>, <strong>not</strong> by affecting<strong> leukotriene synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zileuton directly inhibits the enzyme 5-lipoxygenase, </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">crucial for</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> blocking the synthesis of leukotrienes,</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> particularly</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> leukotriene B4 and cysteinyl leukotrienes,</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> thereby </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">reducing inflammation and bronchoconstriction in asthma patients.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This mechanism is distinct from other asthma medications that either <strong>block receptor activity </strong>or <strong>stabilize cells to prevent mediator release.</strong> Understanding this helps in selecting appropriate therapy for asthma patients with specific inflammatory profiles.</span></span></span></span></span></p>",
      "correct_choice_id": 43443,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}